Here's a look at some of the top Wall Street stories for medical device companies this week: Asante Solutions sets IPO terms; Stryker CEO Lobo: M&A is our top priority for cash; Abiomed surges on Q3 numbers, FDA nod; Credit agencies lower Medtronic's rating post-Covidien merger
Credit agencies Standard & Poor's and Moody's lowered their ratings as promised on Medtronic after it took out a massive debt package to finance its $50 billion acquisition of Covidien.
Covidien and Spectranetics close the $30 million deal for the Stellarex drug-eluting balloon, following the close yesterday of Medtronic's $50 billion acquisition of Covidien.
The largest merger in medtech history closes the same day that the Irish High Court sanctions the $49.9 billion union of Medtronic and Covidien.
Avedro taps ex-Insulet CFO Brian Roberts to be its new finance chief, replacing Rhonda Bracey, who is relocating to the West Coast.
, AtriCure Inc.
, Avedro Inc.
, Given Imaging
, Hologic Inc.
, Insulet Corp.
, Invacare Corp.
, Nextremity Solutions
, OrthoPediatrics Corp.
, Repro-Med Systems Inc.
Covidien issues its final quarterly report as a standalone company, saying its fiscal 1st-quarter earnings beat expectations and it prepares for a $43 billion acquisition by Medtronic next week.
Law firm Greenberg Traurig, MassMEDIC and LB Ventures created Medtech Partnering Day with an eye on putting start-ups and medtech titans together in the same room.
You can't do M&A without a little meet & greet.